… fect the bioavailability of other medicinal products for oral use administered concomitantly.
• Patients with hereditary fructose intolerance (HFI) should not take/be given this medicinal product.
This medicine contains 500 mg of sucrose in each ml. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
This medicine contains 12.35 mg propylene glycol (E1520) in each ml.
• Co-administration with any substrate for alcohol dehydrogenase such as ethanol may induce adverse effects in children less th …
… ffect the bioavailability of other medicinal products for oral use administered concomitantly.
• Patients with hereditary fructose intolerance (HFI) should not take/be given this medicinal product.
This medicine contains 220mg of glucose and 125mg of sucrose in each ml. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
This medicine contains 31.1 mg propylene glycol (E1520) in each ml.
• Co-administration with any substrate for alcohol dehydrogenase such as ethanol may induce adverse effects in children less than …